Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
3.2 Clinical medicine, Expert, Latvian Council of Science
2 Sept 2021 → 1 Sept 2024
3.2 Clinical medicine, Expert, Latvian Council of Science
1 Oct 2018 → 30 Sept 2021
Field of Science
- 3.2 Clinical medicine
Fingerprint
Dive into the research topics where Iveta Ozere is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Dynamics of serum cytokines in patients with pulmonary tuberculosis
Eglīte, J., Koļesova, O., Ozere, I. & Vīksna, A.
1/08/20 → 31/07/21
Project: RSU grants
-
Advantages of analysing both pairwise SNV-distance and differing SNVs between Mycobacterium tuberculosis isolates for recurrent tuberculosis cause determination.
Sadovska, D., Nodieva, A., Pole, I., Ķimsis, J., Vīksna, A., Ozere, I., Norvaiša, I., Bandere, D. & Ranka, R., 1 Mar 2023, In: Microbial genomics. 9, 3, 15 p., 000956.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study
Buonsenso, D., Noguera-Julian, A., Moroni, R., Ozere, I. & PTBNET QFT-Plus Study group, Mar 2023, In: Thorax. 78, 3, p. 288-296 218929.Research output: Contribution to journal › Article › peer-review
Open Access6 Citations (Scopus) -
Assessment of Complete Blood Count-Derived Marker Association With Pulmonary Tuberculosis Severity and Treatment Response
Kivrane, A., Igumnova, V., Viksna, A., Simanovica, I., Ozere, I., Pole, I., Bandere, D. & Ranka, R., 2022, In: Medicina (Kaunas). 58, Suppl.1, p. 48 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Importance of Clinical Pharmacogenetic-Pharmacokinetic Studies in Unravelling Determinants of Tuberculosis Treatment Outcomes: Findings and Implications in Latvia
Igumnova, V., Kivrane, A., Vīksna, A., Freimane, L., Sadovska, D., Čapligina, V., Pahirko, L., Ozere, I., Norvaiša, I., Bogdanova, I., Krams, A., Cīrule, A., Pugovičs, O., Grīnberga, S., Sevostjanovs, E., Bandere, D. & Ranka, R., 2022, In: Medicina (Kaunas). 58, Suppl.1, p. 47 1 p.Research output: Contribution to journal › Meeting Abstract › peer-review
-
Multidisciplināra pieeja latentas tuberkulozes infekcijas diagnostikai un ārstēšanai
Kukša, L., Ozere, I., Stūre, G., Nodieva, A., Rācenis, K. & Buliņa, I., Mar 2022, Latvijas Ārsts, 3, p. 59-61.Research output: Contribution to specialist publication › Specialist article
Activities
-
RSU konference “Praktiskā infektoloģija - šeit un šodien”
Iveta Ozere (Participant)
15 Oct 2022Activity: Participating in or organising an event types › Participating in a conference, workshop, ...
-
Tuberculosis in Children: Prevention, Detection, Diagnosis, and Treatment According to the WHO Consolidated Guidelines on Tuberculosis; Module 5: Management of Tuberculosis in Children and Adolescents
Iveta Ozere (Invited speaker)
6 Sept 2022 → 9 Sept 2022Activity: Talk or presentation types › Invited talk
-
TB diagnostika un ārstēšana bērniem
Iveta Ozere (Speaker)
6 Apr 2022Activity: Talk or presentation types › Oral presentation
-
BCG un jaunumi vakcīnu izstrādē
Iveta Ozere (Speaker)
30 Mar 2022Activity: Talk or presentation types › Oral presentation
-
Tuberkulozes bērniem – kas jauns?
Iveta Ozere (Speaker)
26 Mar 2022Activity: Talk or presentation types › Oral presentation
Press/Media
-
Kāpēc Austrumeiropu Covid-19 skāris vieglāk?' – infektologi par sākto prettuberkulozes vakcīnas pētījumu
29/04/20
1 item of Media coverage
Press/Media